Synergistic Toll-like Receptor 3/9 Signaling Affects Properties and Impairs Glioma-Promoting Activity of Microglia
Authors:
- 6 July 2020
- journal article
- research article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 40 (33) , 6428-6443
Abstract
In murine experimental glioma models, TLR3 or TLR9 activation of microglial/macrophages has been shown to impair glioma growth, which could, however, not been verified in recent clinical trials. We therefore tested whether combined TLR3 and TLR9 activation of microglia/macrophages would have a synergistic effect. Indeed, combined TLR3/TLR9 activation augmented the suppression of glioma growth in organotypic brain slices from male mice in a microglia-dependent fashion, and this synergistic suppression depended on interferon β release and phagocytic tumor clearance. Combined TLR3/TLR9 stimulation also augmented several functional features of microglia, such as the release of proinflammatory factors, motility, and phagocytosis activity. TLR3/TLR9 stimulation combined with CD47 blockade further augmented glioma clearance. Finally, we confirmed that the coactivation of TLR3/TLR9 also augments the impairment of glioma growth in vivo. Our results show that combined activation of TLR3/TLR9 in microglia/macrophages results in a more efficient glioma suppression, which may provide a potential strategy for glioma treatment. SIGNIFICANCE STATEMENT Glioma-associated microglia/macrophages (GAMs) are the predominant immune cells in glioma growth and are recently considered as antitumor targets. TLRs are involved in glioma growth, but the TLR3 or TLR9 ligands were not successful in clinical trials in treating glioma. We therefore combined TLR3 and TLR9 activation of GAMs, resulting in a strong synergistic effect of tumor clearance in vitro, ex vivo, and in vivo. Mechanisms of this GAM-glioma interaction involve IFNβ signaling and increased tumor clearance by GAMs. Interfering with CD47 signaling had an additional impact on tumor clearance. We propose that these signaling pathways could be exploited as anti-glioma targets.Keywords
This publication has 50 references indexed in Scilit:
- Microglia isolated from patients with glioma gain antitumor activities on poly (I:C) stimulationNeuro-Oncology, 2011
- A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastomaNeuro-Oncology, 2010
- IFN-β Restricts Tumor Growth and Sensitizes Alveolar Rhabdomyosarcoma to Ionizing RadiationMolecular Cancer Therapeutics, 2010
- Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II studyNeuro-Oncology, 2010
- The Pathobiology of Glioma TumorsAnnual Review of Pathology: Mechanisms of Disease, 2010
- Innate immunity and neuroinflammation in the CNS: The role of microglia in Toll‐like receptor‐mediated neuronal injuryGlia, 2009
- Gliomas induce and exploit microglial MT1-MMP expression for tumor expansionProceedings of the National Academy of Sciences, 2009
- Development of TLR9 agonists for cancer therapyJournal of Clinical Investigation, 2007
- Cooperation of Toll-like receptor signals in innate immune defenceNature Reviews Immunology, 2007
- Toll-Like Receptor Signaling PathwaysScience, 2003